Monday, May 17, 2010

PharmaTimes | More M&A as big pharma struggles to innovate sufficiently

82% of those polled believe big pharma will be unable to innovate sufficiently from within to replace blockbusters, while 97% expect that patent life extensions will continue to grow in importance. Almost seven in 10 predict substantial acquisition activity within the next two years, while almost two-thirds believe the improved economic situation “means the industry now has the confidence to go ahead with those mergers”.

Posted via web from Jack's posterous

No comments: